class="post-template-default single single-post postid-10839 single-format-standard wp-embed-responsive post-image-above-header post-image-aligned-center sticky-menu-fade right-sidebar nav-below-header separate-containers header-aligned-left dropdown-hover" itemtype="https://schema.org/Blog" itemscope>

Top 20 Stocks Today- Investors and traders can do strong earnings by taking trade in these 20 stocks – Top 20 Stocks Today 24 January 2025 INTRADAY Tips Stocks to Buy and Sell Cyient Bajaj Finance

Top 20 Stocks Today- Today the results of Nifty’s company JSW Steel and Shriram Finance will come. Pressure of 75% is possible in JSW Steel profits. The company’s margin can also be seen strong. The results of 10 futures including DLF IndiGo will also be awaited. Due to this, action can be seen in the shares of other companies of the same sector along with these companies today. The shares of these companies will be eyeing the market. At the same time, 20 strong stocks including Zensar Technologies and Bajaj Finance have been suggested for trading to investors at the direct deal on CNBC-Awaaz. Investors can earn well by investing with their understanding and analysis in it.

Ashish Verma’s team

1) Dr Reddys Laboratories (Red)

Consolidated profits in Q3 on an annual basis increased from Rs 1,379 crore to Rs 1,413.3 crore. Income in Q3 increased from Rs 7,215 crore to Rs 8,358.6 crore

On a quarterly basis, the profit in Q3 declined from Rs 179 crore to Rs 122.3 crore. Income in Q3 increased from Rs 1,849.1 crore to Rs 1,926.4 crore. In Q3, the Ebit declined from Rs 230.6 crore to Rs 211.4 crore. The Ebit margin in Q3 declined from 12.5% ​​to 11%. The company’s CEO and Executive Director Karthikeyan Natarajan resigned

On a quarterly basis, the profit in Q3 increased from Rs 423.3 crore to Rs 427.8 crore. Income in Q3 increased from Rs 3,536.1 crore to Rs 3,561.3 crore

On an annual basis, the profit in Q3 increased from Rs 1,540 crore to Rs 4,003 crore. Income in Q3 increased from Rs 7,199 crore to Rs 7,547 crore

5) Mankind Pharma (Green)

On an annual basis, the profit in Q3 declined from Rs 453.8 crore to Rs 380.2 crore. Income in Q3 increased from Rs 2,607 crore to Rs 3,230 crore

Trade Setup for Today: Consolidation will continue in the market until strong closing above 23400, important support on 23000

Virendra Kumar’s team

The stock made a bullish flag pattern on the charts, it expects a boom.

Shares closed over 50dema after October 21

It closed on its range high. It has seen strong OI addition

Its level of Rs 587 may be its next breakout point.

It is expected to have a range breakout above the Rs 670 level.

Update released —–

(Disclaimer: The ideas and investment advice on Moneycontrol.com have their own personal views and opinions. Moneycontrol advises users to consult certified experts before making any investment decisions.)

Leave a Comment